Synchrony Medical, a respiratory care technology company and creator of the FDA-cleared LibAirty airway clearance system, announced it has secured additional funding through a $1M investment from the New Jersey Innovation Evergreen Fund. Matching an Edge Medical Ventures investment, the funding will be used to accelerate U.S.

Synchrony Medical 是一家呼吸护理技术公司，也是获得 FDA 认证的 LibAirty 气道清除系统的创造者，宣布已通过新泽西创新常青基金的 100 万美元投资获得了额外资金。这笔资金与 Edge Medical Ventures 的投资相匹配，将用于加速其在美国的发展。

commercial operations, support continued clinical research and product development, and expand patient access to LibAirty through respiratory clinics, hospitals, and homecare networks nationwide..

商业运营，支持持续的临床研究和产品开发，并通过全国的呼吸科诊所、医院和家庭护理网络扩大患者对LibAirty的使用。